In this episode, we discuss the current shortage of infant formula in the U.S. with Food and Drug Partner Rick Stearns. In February 2022, a recall of infant formula produced at a single U.S. facility contributed to a major shortage in the infant formula market. To date, FDA continues its efforts to mitigate the effects of this shortage. As the disruptions to infant formula supply now show signs of easing, we look into the underlying causes, trajectory, and FDA intervention. The episode covers FDA oversight of infant formula manufacturing, aimed at ensuring that consumers are presented with safe and quality products that provide suitable nutritional content. Our team also discusses the lasting impact these events may have on the market.